Maharashtra government clears biotechnology policyIllustrative image – not actual.

The Maharashtra government has cleared a biotechnology policy that offers several financial incentives and tax benefits to companies setting up biotech units in the state.

 

The incentives include a lower tax rate under the value added tax (VAT) regime, twice the existing floor space index (FSI) for biotech units, exemption from stamp duty and registration fee and 30 per cent of the fixed capital investment.

 

The highlights include:

 

·           Biotech units can be set up in all regions of the state and would be eligible for incentives available in the state's second least developed regions.

 

·           Units set up in regions where development has already occurred (B, C and D) regions would be eligible for a second tier of incentives. These incentives include capital subsidy for small scale biotechnology units and refund of octroi and similar levies.

 

·           Twice the admissible FSI would be made admissible for units in parks promoted by the Maharashtra Industrial Development Corporation (MIDC) and other public bodies and other yet-to-be-designated locations.

 

·           The original draft policy offered the sales tax floor rate for the next five years for biotech products. But with the VAT regime - to be implemented by 1 April 2002 - the government has decided to offer a very liberalised scheme under this regime, which will be on par with the other incentives offered to biotech units set up in the state.

 

·           New units and the subsequent expansion of existing units will be exempted from payment of stamp duty and registration fees in the developing and backward regions of the state. In other areas, such exemption would be extended to units in biotech parks promoted by public bodies. In private parks, 50 per cent of such stamp duty and registration fees would be waived. In addition, only 10 per cent of the admissible stamp duty would be payable on property transactions resulting from amalgamation of biotech companies.

 

  • The government will encourage the setting up of world class centres of excellence which will cover all aspects of cutting edge R&D in the emerging areas of life sciences and technology. To facilitate this, the state will offer land at concessional rates to such centres of excellence in the area of biotechnology, and norms will be set to define such centres that would be subject to scrutiny and approval on an individual basis.

 

·           The policy proposes to offer infrastructural support to the biotechnology industry. This includes setting up of new biotech parks concentrating on pharmaceuticals and agriculture at Pune and Aurangabad, respectively. Other such park sites would be selected subsequently. Apart from the facilities common to any technology park, the biotech parks will offer GMP facilities in conformity with US Food and Drug Administration norms.

 

·           A business facilitation centre (BFC) will offer services to the clients of the park to create a hassle-free environment. These include a cell for assisting in regulatory and customs clearances and to allow an interface with government bodies; handholding services to entrepreneurs in getting electricity and telephone connections etc; technology transfer and access services; commercialisation services, networking with research institutions; information and support on intellectual property protection. The BFC will provide connectivity with academic and research institutions for providing necessary human resource development base, physical infrastructure such as quality power, telecommunication, connectivity, adequate bandwidth and reliable water supply.

 

·           The government would make available land for building residential complexes for scientists and biotechnology professionals complete with schooling and recreational facilities.

 

·           A biotechnology resource centre would be set up for certification of products after testing them intensively. An experimental animal facility meeting ethical, legal and safety standards would also be set up. The civil construction work for these facilities would depend on contributions from industry and charitable institutions. The government is seeking active participation from NRI, academic and other organisations located abroad for setting up and running these facilities.

 

·           The biotech parks and the resource centre would evolve new patterns of collaboration between research scientists, industry personnel, extension workers, farming community and consumers for wider dissemination and better understanding of costs and benefits of biotechnology.

 

·           On the issue of intellectual property rights (IPR), which is an important issue in the industry as well as the research community, an awareness campaign would be undertaken to educate users and consumers. A special manpower training programme would be developed at the University of Pune, which has already pioneered the forays into IPR by setting up the first CSIR chair in IPR. A special course would be introduced at the postgraduate level in the HRD programmes so as to cover the various aspects of IPR. The curricula for the law faculty would witness the necessary revision and new subjects would be added to incorporate patent law and international IPR-related law courses on high priority.

 

·           The policy notes that unlike other industries, biotech companies are dependent on highly skilled personnel at all levels of operations. The centres supplying such manpower at present would therefore have to be strengthened and diversified; otherwise certain important requirements may remain unmet.

← All latest storiesBack to top →